Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast…
View More Immunotherapy improves responses without reducing quality of life in early breast cancer
Home » immunotherapy »
Rare angiosarcoma tumors respond well to immunotherapy combination
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National…
View More Rare angiosarcoma tumors respond well to immunotherapy combination
Biomaterial-based cancer vaccine combines chemo and immunotherapy to treat triple-negative breast cancer
Patients with cancer have multiple treatment options available to them today, but each has its…
View More Biomaterial-based cancer vaccine combines chemo and immunotherapy to treat triple-negative breast cancer
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
In the scientific journal Nature Medicine, researchers in the Netherlands report that neoadjuvant immunotherapy using…
View More Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that…
View More FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
Study examines kidney injury in patients taking immunotherapy cancer medications
A new study indicates that kidney damage is fairly common in patients who take immunotherapy…
View More Study examines kidney injury in patients taking immunotherapy cancer medications
Study shows why a common form of immunotherapy fails, and suggests solution
New research has uncovered a mechanism thought to explain why some cancers don’t respond to…
View More Study shows why a common form of immunotherapy fails, and suggests solution
Oral immunotherapy safe for preschool-aged children with peanut allergies
New data published this week in the Journal of Allergy and Clinical Immunology: In Practice…
View More Oral immunotherapy safe for preschool-aged children with peanut allergies